Halozyme is not holding back against Merck & Co. in the companies' injectable Keytruda patent dispute, having now escalated a verbal warning into a lawsuit. In a lawsuit filed Thursday in a New ...

Caroline Litchfield; Chief Financial Officer, Executive Vice President; Merck & Co Inc Dean Li; Executive Vice President, President - Merck Research Laboratories; Merck & Co Inc Thank you for ...

Merck expects $200 million in added tariff costs, primarily impacting gross margins. The company has invested $12 billion since 2017, with another $9 billion planned to expand U.S. manufacturing ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China. The estimate doesn’t account for the possibility that ...

Former Sony indie boss Shuhei Yoshida has suggested the former holder needs to move on from dazzling with flashy visuals and change its ‘way of thinking’ going forward. Speaking with AV Watch ...

RAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $5.08 billion. On a per-share basis, the Rahway, New Jersey-based company said it had ...

Merck & Co. cut its 2025 earnings outlook, partly to account for recently imposed tariffs that it projects will total $200 million. The projection comes in light of the tariffs implemented so ...

Former President of Sony Interactive Entertainment Worldwide Studios Shuhei Yoshida in an interview with AVWatch (and translated by Genki) said PlayStation should reconsider its focus on having ...

Merck KGaA is nearing a deal to acquire SpringWorks Therapeutics Inc., people familiar with the matter said. An announcement may come as soon as Monday, the people said, asking not to be ...

Merck KGaA is edging closer to the SpringWorks deal, which was first rumoured in February, confirming late-stage negotiations at an estimated price of $47 per share – potentially valuing the ...

Shuhei Yoshida's podcast victory lap continues with an appearance on the Easy Allies podcast, where he heaped praise on Sucker Punch Productions and its upcoming game, Ghost of Yotei. As the game ...

Reacting to press speculation, Merck KGaA has acknowledged that talks to buy US biotech SpringWorks are now in the late stages and are revolving around an offer of around $47 per share.